| Related Articles |
Difluoromethylornithine in cancer: new advances.
Future Oncol. 2017 Jan 27;:
Authors: Alexiou GA, Lianos GD, Ragos V, Galani V, Kyritsis AP
Abstract
Difluoromethylornithine (DFMO; eflornithine) is an irreversible suicide inhibitor of the enzyme ornithine decarboxylase which is involved in polyamine synthesis. Polyamines are important for cell survival, thus DFMO was studied as an anticancer agent and as a chemoprevention agent. DFMO exhibited mainly cytostatic activity and had single agent efficacy as well as activity in combination with other chemotherapeutic drugs for some cancers and leukemias. Herewith, we summarize the current knowledge of the anticancer and chemopreventive properties of DFMO and assess the status of clinical trials.
PMID: 28125906 [PubMed - as supplied by publisher]
http://ift.tt/2kxiqrB
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου